跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 25,362 条关于
“AXL inhibitor”
全部
25,362
临床试验
14,232
药物
4,535
机构
76
资讯
6,519
去年
BerGenBio's AXL Inhibitor Receives FDA Fast Track for STK11-Mutated Cancers Amidst Leadership Transition
去年
BerGenBio's AXL Inhibitor Shows Promise in STK11-Mutated Lung Cancer, Faces Leadership Transition
去年
Immunotherapy Strategies Evolving for NSCLC with KRAS and STK11 Mutations
去年
BerGenBio's Bemcentinib Enters Clinical Trial for Advanced Lung Adenocarcinoma
去年
Qurient Initiates Phase 1 Trial of Adrixetinib for Relapsed/Refractory AML
去年
Qurient's Adrixetinib Receives FDA IND Approval for cGVHD Trial
11个月前
Qurient and Synaffix Partner to Develop First-in-Class CDK7 Dual-Payload ADC for Refractory Cancers
去年
Comprehensive Genomic Analysis Reveals Key Metastatic Pathways and Drug Targets in Thyroid Cancer
去年
Axelyf Closes $2.6M Seed Round to Advance Superior RNA-LNP Gene Editing Technology
去年
Over 120 Pipeline Therapies Target Acute Myeloid Leukemia as Research Intensifies
第 1 页,共 652 页
上一页
下一页